Some genetic changes including some tumor susceptibility genes or driver genes such as CCND1, FGF19, GATA3, KMT2C, MEN1, TP53, BRCA2, PI3KC3 and a fusion between ERCC2 and KLC3, were identified via NGS test of the liver metastasis tissue. The gene discussed is BRCA2; the disease is neoplasm.